InsidersTradesSigma
Track the HUM share price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Healthcare & Pharma sector, HUM has logged 4 insider filings. Market capitalisation: €232.3m. The latest transaction was filed on 14 May 2026 (Other). Among the most active insiders: substantial holder on 13 / 05 / 2026. Every trade is accessible without an account.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,066 of 28,857 companies
64.3
score / 100
Value79
Quality50
FCF yld73%
Earn yld18%
EV/EBITDA13.2x
ROE4.8%
Gross mgn95%
Net mgn6.1%
Debt/EBITDA12.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 May 2026
Declarations4 total
ShareASXASX:2924-03090173-2A1672112
ShareASXASX:2924-03090172-2A1672111
ShareASXASX:2924-03090146-2A1672095
ShareASXASX:2924-03090145-2A1672094
4 of 4 declarations
About HUM
HUM is a company operating in the health and pharmaceutical sector, listed on the XASX market. It focuses on the development and commercialization of innovative solutions to improve patient health.
